[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:esophageal-carcinoma:msi1-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Esophageal Carcinoma","MSI1 Gene",5,[8,16,23,29,35],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07001592","Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors",[12],"Phase 1","RECRUITING","2026-08-26T02:16:44.178623Z","2026-05-05T02:43:28.887551Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT03526835","A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors",[20],"Phase 1\u002FPhase 2","2026-08-26T02:17:16.126291Z","2026-07-30T01:46:14.461456Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07354100","Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy",[20],"2026-08-26T02:18:52.966503Z","2026-06-17T02:29:30.060269Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT05086692","A Beta-only IL-2 ImmunoTherapY Study",[20],"2026-08-26T02:18:31.164304Z","2026-05-05T02:35:31.708594Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06349642","Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform",[],"2026-08-26T02:17:03.534765Z","2026-05-13T02:55:06.483978Z"]